Latest DEF 14A proxy statements

Summit Networks, Inc. informs shareholders of actions approved by majority consent, including director elections, audit committee appointments, and auditor ratification.

Banzai International, Inc. filed additional proxy materials to correct clerical errors regarding its independent auditor and audit report dating in its definitive proxy statement.

RYVYL's merger partner, RTB Digital, Inc., secured an additional $10 million investment from UTXO Management, bringing its total recent capital raise to $43 million, which is expected to boost RYVYL's shareholder equity post-merger.

Johnson Outdoors Inc. announces its 2026 Annual Meeting of Stockholders to address director elections, auditor ratification, executive compensation, and amendments to stock incentive plans.

Exact Sciences Corporation will be acquired by Abbott Laboratories for $105.00 per share in cash, representing a significant premium to recent trading prices.

Agape ATP Corporation will hold its Annual Meeting on January 30, 2026, seeking shareholder approval for a significant capital raise, a reverse stock split, and an increase in authorized shares to support future growth and strategic initiatives.

TrueBlue, Inc. sent an email to employees addressing a public letter from investor EHS Management, reaffirming its strategic plan and recent Board additions.

TrueBlue, Inc. issued a statement defending its strategic plan and recent board changes against director nominations from EHS Management, LLC ahead of its 2026 annual meeting.

Faraday Future Intelligent Electric Inc. calls a Special Meeting to vote on increasing authorized shares by 34% and changing its name to Faraday Future AI Electric Vehicle Inc.

Prospect Capital Corporation announced the adjournment of its annual meeting of stockholders to January 15, 2026, to allow more time for vote solicitation.

Apple Inc. has announced the agenda for its 2026 Annual Meeting of Shareholders, including director elections, auditor ratification, executive compensation, and a shareholder proposal.

Oaktree Specialty Lending Corporation is seeking stockholder approval to issue up to 25% of its common stock below net asset value per share, citing future flexibility.

VESTIS CORPORATION has filed definitive additional materials related to its Schedule 14A proxy statement.

Eagle Point Income Company Inc. seeks stockholder approval to convert from a Delaware corporation to a Delaware statutory trust, aiming for operational efficiencies and greater flexibility.

Apple Inc. releases its definitive proxy statement for the 2026 Annual Meeting, detailing director nominations, executive compensation, and shareholder proposals, following a record-breaking fiscal year 2025.

Oaktree Specialty Lending Corporation is seeking stockholder approval to issue up to 25% of its common stock below net asset value per share to enhance financial flexibility and pursue investment opportunities.

Vestis Corporation details a comprehensive multi-year strategic transformation plan and leadership changes in its latest proxy statement, following a pivotal fiscal 2025 with positive free cash flow but no annual incentive payouts.

Modular Medical, Inc. will hold its fiscal 2026 Annual Meeting to address Nasdaq compliance, approve a reverse stock split, increase authorized shares, and amend its equity incentive plan amidst going concern doubts.

Ventyx Biosciences has agreed to be acquired by Eli Lilly, a transaction expected to close in the first half of 2026.

Eli Lilly and Company will acquire Ventyx Biosciences, Inc. for $1.2 billion in an all-cash transaction, offering shareholders a 62% premium.

Ventyx Biosciences announced an agreement to be acquired by Eli Lilly, expecting to close the transaction in the first half of 2026.

Ventyx Biosciences announced an agreement to be acquired by Eli Lilly for $14.00 per share in cash, representing a 62% premium.

Ventyx Biosciences announces an agreement to be acquired by Eli Lilly, with the transaction expected to close in the first half of 2026.

Ventyx Biosciences announces its acquisition by Eli Lilly and Company for $14.00 per share in cash, expected to close in the first half of 2026.

Ventyx Biosciences has entered into a definitive agreement to be acquired by Eli Lilly and Company, aiming to enhance patient impact in autoimmune, inflammatory, and neurodegenerative diseases.

CSG Systems International, Inc. announced the expiration of the US antitrust waiting period for its merger with NEC Corporation, marking a significant step towards closing the transaction.

Ventyx Biosciences announced its agreement to be acquired by Eli Lilly for $14.00 per share in cash, a move expected to advance its pipeline in autoimmune, inflammatory, and neurodegenerative diseases.

Bitmine Immersion Technologies, Inc. Chairman Tom Lee urges shareholders to vote on an important proposal ahead of the January 14th deadline for the upcoming Annual Meeting.

ECD Automotive Design, Inc. issued a definitive additional materials filing to correct the outstanding shares and quorum information for its upcoming Special Meeting.

CaliberCos Inc. will hold a Special Meeting on January 30, 2026, to vote on increasing authorized Class A common stock, amending written consent rules, and expanding its equity incentive plan.